Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | TUBB4A | P04350 | 6/20 | 0.37 |
| ▸ | TUBB | P07437 | 6/20 | 0.37 |
| ▸ | TUBA3C | P0DPH7 | 6/20 | 0.37 |
| ▸ | TUBA1B | P68363 | 6/20 | 0.37 |
| ▸ | TUBA4A | P68366 | 6/20 | 0.37 |
| ▸ | TUBB4B | P68371 | 6/20 | 0.37 |
| ▸ | TUBB3 | Q13509 | 6/20 | 0.37 |
| ▸ | TUBB2A | Q13885 | 6/20 | 0.37 |
| ▸ | TUBB8 | Q3ZCM7 | 6/20 | 0.37 |
| ▸ | TUBA3E | Q6PEY2 | 6/20 | 0.37 |
| ▸ | TUBA1A | Q71U36 | 6/20 | 0.37 |
| ▸ | TUBA1C | Q9BQE3 | 6/20 | 0.37 |
| ▸ | TUBB6 | Q9BUF5 | 6/20 | 0.37 |
| ▸ | TUBB2B | Q9BVA1 | 6/20 | 0.37 |
| ▸ | TUBB1 | Q9H4B7 | 6/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13330407 | 0.87 | CNR2 (0.40) | CNR2SMN1; SMN2KMT2AMEN1 | |
| SCHEMBL13330423 | 0.87 | CNR2 (0.42) | CNR2SMN1; SMN2KMT2AMEN1 | |
| SCHEMBL13330455 | 0.84 | CNR2 (0.45) | CNR2SMN1; SMN2TSHRTUBB4ATUBB | |
| SCHEMBL28276198 | 0.77 | CNR2 (0.62) | CNR2SMN1; SMN2TSHRTUBB4ATUBB | |
| SCHEMBL13330434 | 0.75 | FAAH (0.39) | CNR2SMN1; SMN2KMT2AMAPTMEN1 | |
| SCHEMBL13330418 | 0.75 | FAAH (0.39) | CNR2SMN1; SMN2KMT2AMAPTMEN1 | |
| SCHEMBL13330459 | 0.74 | ALDH1A1 (0.32) | SMN1; SMN2MAPK1KDM4EALDH1A1 | |
| SCHEMBL13330449 | 0.72 | CNR2 (0.44) | CNR2SMN1; SMN2TSHRKMT2AMAPT | |
| SCHEMBL13330414 | 0.72 | CNR2 (0.44) | CNR2KMT2AMEN1 | |
| SCHEMBL13330402 | 0.72 | RARA (0.49) | CNR2KMT2AMAPTMEN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100113816-A1 | METHOD FOR PREPARTION OF SUBSTITUTED ADAMANTYLARYMAGNESIUM HALIDES | JSC GRINDEKS (LV) | 2010-05-06 | — | — | US | disclosed |
| US-20100113816-A1 | METHOD FOR PREPARTION OF SUBSTITUTED ADAMANTYLARYMAGNESIUM HALIDES | JSC GRINDEKS (LV) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113816-A1 | METHOD FOR PREPARTION OF SUBSTITUTED ADAMANTYLARYMAGNESIUM HALIDES | AGL, MACROD1, MACROD2 | CNR2 1967/4885SMN1; SMN2 4655/4885TSHR 2667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.